Apexigen, Inc.
APGN · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $1,753 | $2,937 | $4,239 | $5,683 |
| G&A Expenses | $4,405 | $3,279 | $2,411 | $3,116 |
| SG&A Expenses | $4,405 | $3,279 | $2,411 | $3,116 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $6,158 | $6,216 | $6,650 | $8,799 |
| Operating Income | -$6,158 | -$6,216 | -$6,650 | -$8,799 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $111 | $163 | $219 | $307 |
| Pre-Tax Income | -$6,047 | -$6,053 | -$6,431 | -$8,492 |
| Tax Expense | $0 | -$163 | $107 | -$307 |
| Net Income | -$6,047 | -$5,890 | -$6,538 | -$8,185 |
| % Margin | – | – | – | – |
| EPS | -0.24 | -0.24 | -330.41 | -0.4 |
| % Growth | 0% | 99.9% | -82,502.5% | – |
| EPS Diluted | -0.24 | -0.24 | -330.41 | -0.4 |
| Weighted Avg Shares Out | 24,726 | 24,157 | 20 | 20,484 |
| Weighted Avg Shares Out Dil | 24,726 | 24,157 | 20 | 20,484 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $122 | $17 | $26 | $52 |
| EBITDA | -$6,158 | -$6,199 | -$13,568 | -$8,799 |
| % Margin | – | – | – | – |